Ambea AB (publ) has made a public offer for all shares in Humana AB. The offer values all shares in Humana at approximately SEK 2,96 billion. The consideration consists of a mix of shares, cash and a CVR (contingent value right).

Vinge’s team primarily consists of Sofie Bjärtun, Linnéa Dolk, Anna Svensson, Lorin Arabi och Samuel Rapp (Capital Markets and Public M&A), Christina Kokko, Samra Tesser, Elsie Nassar och Hedvig Merkel (M&A), Albert Wållgren, Josefine Lanker, Kamyar Najmi och Sara Eirefors (Banking and Finance), Eva Fredrikson, Christoffer Nordin, Nicklas Thorgerzon och Mario Saad (Corporate Commercial), Marcus Glader, Jakob Rosini Jeanrond, Martin Bergqvist, Daniel Wendelsson och Kristoffer Sällfors (Competition and FDI), Maria Schultzberg, Victor Ericsson, Erik Kochbati, Marcus Svärd, Elsa Kalén och Axel Åshuvud (Corporate Tax), Vilma Simonius (Compliance)  samt Alice Vångell (Transaction Support Coordinator).

Related

Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme

Vinge has advised Röko AB (publ) ("Röko") on the establishment of a medium-term note programme (the "MTN Programme") with a framework amount of SEK 5 billion.
November 13, 2026

Vinge advises Telavox on the sale of its Nordic customer base to Telia

Vinge has advised Telavox AB (“Telavox”) on the sale of Telavox’s Nordic customer base for business services to Telia Company AB (“Telia”). The customer base comprises approximately 24,000 business customers and 325,000 end users in Sweden, Denmark, Finland, and Norway. The purchase price amounts to SEK 3.8 billion plus a potential additional earn-out.
November 13, 2026

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026